APO Research
Talk to an analyst

APO RESEARCH · REPORT

Whole Plasmid Sequencing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Whole Plasmid Sequencing Market Analysis and Forecast 2026-2032

16 April 2026205 pages

Choose your research edition.

Industry ResearchWhole Plasmid Sequencing Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Whole Plasmid Sequencing Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Whole Plasmid Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Whole Plasmid Sequencing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Whole Plasmid Sequencing Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Whole Plasmid Sequencing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Whole Plasmid Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Whole Plasmid Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Whole Plasmid Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Whole Plasmid Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Whole Plasmid Sequencing include Eurofins Genomics, GenScript, Plasmidsaurus, Genewiz, Macrogen Europe, Source BioScience, Psomagen, BaseClear B.V. and Molecular Cloning Laboratories (MCLAB), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Whole Plasmid Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Whole Plasmid Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Whole Plasmid Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Whole Plasmid Sequencing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Whole Plasmid Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Whole Plasmid Sequencing revenue, projected growth trends, production technology, application and end-user industry.

Whole Plasmid Sequencing Segment by Company

Eurofins Genomics

GenScript

Plasmidsaurus

Genewiz

Macrogen Europe

Source BioScience

Psomagen

BaseClear B.V.

Molecular Cloning Laboratories (MCLAB)

Polyplus

Elim Biopharm

SnapGene

Full Circle Labs

Unveil Bio

Microsynth AG

CD Genomics

Whole Plasmid Sequencing Segment by Type

Plasmid Regular (2.5 – 25 kb)

Plasmid Large (25 – 125 kb)

Plasmid XL (125 – 300 kb)

Others

Whole Plasmid Sequencing Segment by Application

Biopharmaceutical Companies

Research Institutions

Others

Whole Plasmid Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Plasmid Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Whole Plasmid Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Plasmid Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Whole Plasmid Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Whole Plasmid Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Whole Plasmid Sequencing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Whole Plasmid Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Plasmid Regular (2.5 – 25 kb) Major Player Table 3. Plasmid Large (25 – 125 kb) Major Player Table 4. Plasmid XL (125 – 300 kb) Major Player Table 5. Others Major Player Table 6. Global Whole Plasmid Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Biopharmaceutical Companies Major Player Table 8. Research Institutions Major Player Table 9. Others Major Player Table 10. Whole Plasmid Sequencing Industry Trends Table 11. Whole Plasmid Sequencing Industry Drivers Table 12. Whole Plasmid Sequencing Industry Opportunities and Challenges Table 13. Whole Plasmid Sequencing Industry Restraints Table 14. Global Whole Plasmid Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Whole Plasmid Sequencing Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Whole Plasmid Sequencing Market Share by Region (2021-2026) Table 17. Global Whole Plasmid Sequencing Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Whole Plasmid Sequencing Market Share by Region (2027-2032) Table 19. Global Whole Plasmid Sequencing Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Whole Plasmid Sequencing Revenue Market Share by Players (2021-2026) Table 21. Global Whole Plasmid Sequencing Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Whole Plasmid Sequencing Key Players Headquarters & Area Served Table 23. Global Whole Plasmid Sequencing Players, Product Type & Application Table 24. Global Whole Plasmid Sequencing Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Whole Plasmid Sequencing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Whole Plasmid Sequencing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Whole Plasmid Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Whole Plasmid Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Whole Plasmid Sequencing Revenue Market Share by Type (2021-2026) Table 31. Global Whole Plasmid Sequencing Revenue Market Share by Type (2027-2032) Table 32. Global Whole Plasmid Sequencing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Whole Plasmid Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Whole Plasmid Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Whole Plasmid Sequencing Revenue Market Share by Application (2021-2026) Table 36. Global Whole Plasmid Sequencing Revenue Market Share by Application (2027-2032) Table 37. Eurofins Genomics Company Information Table 38. Eurofins Genomics Business Overview Table 39. Eurofins Genomics Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Eurofins Genomics Whole Plasmid Sequencing Product Portfolio Table 41. Eurofins Genomics Recent Development Table 42. GenScript Company Information Table 43. GenScript Business Overview Table 44. GenScript Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. GenScript Whole Plasmid Sequencing Product Portfolio Table 46. GenScript Recent Development Table 47. Plasmidsaurus Company Information Table 48. Plasmidsaurus Business Overview Table 49. Plasmidsaurus Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Plasmidsaurus Whole Plasmid Sequencing Product Portfolio Table 51. Plasmidsaurus Recent Development Table 52. Genewiz Company Information Table 53. Genewiz Business Overview Table 54. Genewiz Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Genewiz Whole Plasmid Sequencing Product Portfolio Table 56. Genewiz Recent Development Table 57. Macrogen Europe Company Information Table 58. Macrogen Europe Business Overview Table 59. Macrogen Europe Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Macrogen Europe Whole Plasmid Sequencing Product Portfolio Table 61. Macrogen Europe Recent Development Table 62. Source BioScience Company Information Table 63. Source BioScience Business Overview Table 64. Source BioScience Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Source BioScience Whole Plasmid Sequencing Product Portfolio Table 66. Source BioScience Recent Development Table 67. Psomagen Company Information Table 68. Psomagen Business Overview Table 69. Psomagen Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Psomagen Whole Plasmid Sequencing Product Portfolio Table 71. Psomagen Recent Development Table 72. BaseClear B.V. Company Information Table 73. BaseClear B.V. Business Overview Table 74. BaseClear B.V. Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. BaseClear B.V. Whole Plasmid Sequencing Product Portfolio Table 76. BaseClear B.V. Recent Development Table 77. Molecular Cloning Laboratories (MCLAB) Company Information Table 78. Molecular Cloning Laboratories (MCLAB) Business Overview Table 79. Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Product Portfolio Table 81. Molecular Cloning Laboratories (MCLAB) Recent Development Table 82. Polyplus Company Information Table 83. Polyplus Business Overview Table 84. Polyplus Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Polyplus Whole Plasmid Sequencing Product Portfolio Table 86. Polyplus Recent Development Table 87. Elim Biopharm Company Information Table 88. Elim Biopharm Business Overview Table 89. Elim Biopharm Whole Plasmid Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Elim Biopharm Whole Plasmid Sequencing Product Portfolio Table 91. Elim Biopharm Recent Development Table 92. SnapGene Company Information Table 93. SnapGene Business Overview Table 94. SnapGene Whole Plasmid Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. SnapGene Whole Plasmid Sequencing Product Portfolio Table 96. SnapGene Recent Development Table 97. Full Circle Labs Company Information Table 98. Full Circle Labs Business Overview Table 99. Full Circle Labs Whole Plasmid Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Full Circle Labs Whole Plasmid Sequencing Product Portfolio Table 101. Full Circle Labs Recent Development Table 102. Unveil Bio Company Information Table 103. Unveil Bio Business Overview Table 104. Unveil Bio Whole Plasmid Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Unveil Bio Whole Plasmid Sequencing Product Portfolio Table 106. Unveil Bio Recent Development Table 107. Microsynth AG Company Information Table 108. Microsynth AG Business Overview Table 109. Microsynth AG Whole Plasmid Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Microsynth AG Whole Plasmid Sequencing Product Portfolio Table 111. Microsynth AG Recent Development Table 112. CD Genomics Company Information Table 113. CD Genomics Business Overview Table 114. CD Genomics Whole Plasmid Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. CD Genomics Whole Plasmid Sequencing Product Portfolio Table 116. CD Genomics Recent Development Table 117. North America Whole Plasmid Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Whole Plasmid Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Whole Plasmid Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Whole Plasmid Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Whole Plasmid Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Whole Plasmid Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 123. North America Whole Plasmid Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 124. Europe Whole Plasmid Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Whole Plasmid Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Whole Plasmid Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Whole Plasmid Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Whole Plasmid Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Whole Plasmid Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 130. Europe Whole Plasmid Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 131. China Whole Plasmid Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 132. China Whole Plasmid Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 133. China Whole Plasmid Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 134. China Whole Plasmid Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Whole Plasmid Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Whole Plasmid Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Whole Plasmid Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Whole Plasmid Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Whole Plasmid Sequencing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Whole Plasmid Sequencing Revenue by Region (US$ Million) & (2021-2026) Table 141. Asia Whole Plasmid Sequencing Revenue by Region (US$ Million) & (2027-2032) Table 142. SAMEA Whole Plasmid Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 143. SAMEA Whole Plasmid Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 144. SAMEA Whole Plasmid Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 145. SAMEA Whole Plasmid Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 146. SAMEA Whole Plasmid Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. SAMEA Whole Plasmid Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 148. SAMEA Whole Plasmid Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Whole Plasmid Sequencing Image Figure 2. Global Whole Plasmid Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Whole Plasmid Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Plasmid Regular (2.5 – 25 kb) Image Figure 5. Plasmid Large (25 – 125 kb) Image Figure 6. Plasmid XL (125 – 300 kb) Image Figure 7. Others Image Figure 8. Global Whole Plasmid Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Whole Plasmid Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 10. Biopharmaceutical Companies Image Figure 11. Research Institutions Image Figure 12. Others Image Figure 13. Global Whole Plasmid Sequencing Market Size (US$ Million) & (2021-2032) Figure 14. Global Whole Plasmid Sequencing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Whole Plasmid Sequencing Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Whole Plasmid Sequencing Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Whole Plasmid Sequencing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Whole Plasmid Sequencing Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Whole Plasmid Sequencing Revenue Market Share by Type (2021-2032) Figure 21. Global Whole Plasmid Sequencing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Whole Plasmid Sequencing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Whole Plasmid Sequencing Revenue Market Share by Application (2021-2032) Figure 24. North America Whole Plasmid Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Whole Plasmid Sequencing Revenue Share by Type (2021-2032) Figure 26. North America Whole Plasmid Sequencing Revenue Share by Application (2021-2032) Figure 27. North America Whole Plasmid Sequencing Revenue Share by Country (2021-2032) Figure 28. United States Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Whole Plasmid Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Whole Plasmid Sequencing Revenue Share by Type (2021-2032) Figure 33. Europe Whole Plasmid Sequencing Revenue Share by Application (2021-2032) Figure 34. Europe Whole Plasmid Sequencing Revenue Share by Country (2021-2032) Figure 35. Germany Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Whole Plasmid Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Whole Plasmid Sequencing Revenue Share by Type (2021-2032) Figure 45. China Whole Plasmid Sequencing Revenue Share by Application (2021-2032) Figure 46. Asia Whole Plasmid Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Whole Plasmid Sequencing Revenue Share by Type (2021-2032) Figure 48. Asia Whole Plasmid Sequencing Revenue Share by Application (2021-2032) Figure 49. Asia Whole Plasmid Sequencing Revenue Share by Region (2021-2032) Figure 50. Japan Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Whole Plasmid Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Whole Plasmid Sequencing Revenue Share by Type (2021-2032) Figure 58. SAMEA Whole Plasmid Sequencing Revenue Share by Application (2021-2032) Figure 59. SAMEA Whole Plasmid Sequencing Revenue Share by Country (2021-2032) Figure 60. Brazil Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Whole Plasmid Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmid Regular (2.5 – 25 kb)
  • Plasmid Large (25 – 125 kb)
  • Plasmid XL (125 – 300 kb)
  • Others
Applications
  • Biopharmaceutical Companies
  • Research Institutions
  • Others
Companies covered
  • Eurofins Genomics
  • GenScript
  • Plasmidsaurus
  • Genewiz
  • Macrogen Europe
  • Source BioScience
  • Psomagen
  • BaseClear B.V.
  • Molecular Cloning Laboratories (MCLAB)
  • Polyplus
  • Elim Biopharm
  • SnapGene
  • Full Circle Labs
  • Unveil Bio
  • Microsynth AG
  • CD Genomics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Whole Plasmid Sequencing Market by Type
  3. 1.2.1 Global Whole Plasmid Sequencing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Plasmid Regular (2.5 – 25 kb)
  5. 1.2.3 Plasmid Large (25 – 125 kb)
  6. 1.2.4 Plasmid XL (125 – 300 kb)
  7. 1.2.5 Others
  8. 1.3 Whole Plasmid Sequencing Market by Application
  9. 1.3.1 Global Whole Plasmid Sequencing Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Biopharmaceutical Companies
  11. 1.3.3 Research Institutions
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Whole Plasmid Sequencing Market Dynamics
  1. 2.1 Whole Plasmid Sequencing Industry Trends
  2. 2.2 Whole Plasmid Sequencing Industry Drivers
  3. 2.3 Whole Plasmid Sequencing Industry Opportunities and Challenges
  4. 2.4 Whole Plasmid Sequencing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Whole Plasmid Sequencing Market Perspective (2021-2032)
  2. 3.2 Global Whole Plasmid Sequencing Growth Trends by Region
  3. 3.2.1 Global Whole Plasmid Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Whole Plasmid Sequencing Market Size by Region (2021-2026)
  5. 3.2.3 Global Whole Plasmid Sequencing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Whole Plasmid Sequencing Revenue by Players
  2. 4.1.1 Global Whole Plasmid Sequencing Revenue by Players (2021-2026)
  3. 4.1.2 Global Whole Plasmid Sequencing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Whole Plasmid Sequencing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Whole Plasmid Sequencing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Whole Plasmid Sequencing Key Players Headquarters & Area Served
  7. 4.4 Global Whole Plasmid Sequencing Players, Product Type & Application
  8. 4.5 Global Whole Plasmid Sequencing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Whole Plasmid Sequencing Market CR5 and HHI
  11. 4.6.3 2025 Whole Plasmid Sequencing Tier 1, Tier 2, and Tier 3
5 Whole Plasmid Sequencing Market Size by Type
  1. 5.1 Global Whole Plasmid Sequencing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Whole Plasmid Sequencing Revenue by Type (2021-2032)
  3. 5.3 Global Whole Plasmid Sequencing Revenue Market Share by Type (2021-2032)
6 Whole Plasmid Sequencing Market Size by Application
  1. 6.1 Global Whole Plasmid Sequencing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Whole Plasmid Sequencing Revenue by Application (2021-2032)
  3. 6.3 Global Whole Plasmid Sequencing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins Genomics
  2. 7.1.1 Eurofins Genomics Company Information
  3. 7.1.2 Eurofins Genomics Business Overview
  4. 7.1.3 Eurofins Genomics Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Genomics Whole Plasmid Sequencing Product Portfolio
  6. 7.1.5 Eurofins Genomics Recent Developments
  7. 7.2 GenScript
  8. 7.2.1 GenScript Company Information
  9. 7.2.2 GenScript Business Overview
  10. 7.2.3 GenScript Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GenScript Whole Plasmid Sequencing Product Portfolio
  12. 7.2.5 GenScript Recent Developments
  13. 7.3 Plasmidsaurus
  14. 7.3.1 Plasmidsaurus Company Information
  15. 7.3.2 Plasmidsaurus Business Overview
  16. 7.3.3 Plasmidsaurus Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Plasmidsaurus Whole Plasmid Sequencing Product Portfolio
  18. 7.3.5 Plasmidsaurus Recent Developments
  19. 7.4 Genewiz
  20. 7.4.1 Genewiz Company Information
  21. 7.4.2 Genewiz Business Overview
  22. 7.4.3 Genewiz Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Genewiz Whole Plasmid Sequencing Product Portfolio
  24. 7.4.5 Genewiz Recent Developments
  25. 7.5 Macrogen Europe
  26. 7.5.1 Macrogen Europe Company Information
  27. 7.5.2 Macrogen Europe Business Overview
  28. 7.5.3 Macrogen Europe Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Macrogen Europe Whole Plasmid Sequencing Product Portfolio
  30. 7.5.5 Macrogen Europe Recent Developments
  31. 7.6 Source BioScience
  32. 7.6.1 Source BioScience Company Information
  33. 7.6.2 Source BioScience Business Overview
  34. 7.6.3 Source BioScience Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Source BioScience Whole Plasmid Sequencing Product Portfolio
  36. 7.6.5 Source BioScience Recent Developments
  37. 7.7 Psomagen
  38. 7.7.1 Psomagen Company Information
  39. 7.7.2 Psomagen Business Overview
  40. 7.7.3 Psomagen Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Psomagen Whole Plasmid Sequencing Product Portfolio
  42. 7.7.5 Psomagen Recent Developments
  43. 7.8 BaseClear B.V.
  44. 7.8.1 BaseClear B.V. Company Information
  45. 7.8.2 BaseClear B.V. Business Overview
  46. 7.8.3 BaseClear B.V. Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BaseClear B.V. Whole Plasmid Sequencing Product Portfolio
  48. 7.8.5 BaseClear B.V. Recent Developments
  49. 7.9 Molecular Cloning Laboratories (MCLAB)
  50. 7.9.1 Molecular Cloning Laboratories (MCLAB) Company Information
  51. 7.9.2 Molecular Cloning Laboratories (MCLAB) Business Overview
  52. 7.9.3 Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Product Portfolio
  54. 7.9.5 Molecular Cloning Laboratories (MCLAB) Recent Developments
  55. 7.10 Polyplus
  56. 7.10.1 Polyplus Company Information
  57. 7.10.2 Polyplus Business Overview
  58. 7.10.3 Polyplus Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Polyplus Whole Plasmid Sequencing Product Portfolio
  60. 7.10.5 Polyplus Recent Developments
  61. 7.11 Elim Biopharm
  62. 7.11.1 Elim Biopharm Company Information
  63. 7.11.2 Elim Biopharm Business Overview
  64. 7.11.3 Elim Biopharm Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Elim Biopharm Whole Plasmid Sequencing Product Portfolio
  66. 7.11.5 Elim Biopharm Recent Developments
  67. 7.12 SnapGene
  68. 7.12.1 SnapGene Company Information
  69. 7.12.2 SnapGene Business Overview
  70. 7.12.3 SnapGene Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 SnapGene Whole Plasmid Sequencing Product Portfolio
  72. 7.12.5 SnapGene Recent Developments
  73. 7.13 Full Circle Labs
  74. 7.13.1 Full Circle Labs Company Information
  75. 7.13.2 Full Circle Labs Business Overview
  76. 7.13.3 Full Circle Labs Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Full Circle Labs Whole Plasmid Sequencing Product Portfolio
  78. 7.13.5 Full Circle Labs Recent Developments
  79. 7.14 Unveil Bio
  80. 7.14.1 Unveil Bio Company Information
  81. 7.14.2 Unveil Bio Business Overview
  82. 7.14.3 Unveil Bio Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Unveil Bio Whole Plasmid Sequencing Product Portfolio
  84. 7.14.5 Unveil Bio Recent Developments
  85. 7.15 Microsynth AG
  86. 7.15.1 Microsynth AG Company Information
  87. 7.15.2 Microsynth AG Business Overview
  88. 7.15.3 Microsynth AG Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Microsynth AG Whole Plasmid Sequencing Product Portfolio
  90. 7.15.5 Microsynth AG Recent Developments
  91. 7.16 CD Genomics
  92. 7.16.1 CD Genomics Company Information
  93. 7.16.2 CD Genomics Business Overview
  94. 7.16.3 CD Genomics Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 CD Genomics Whole Plasmid Sequencing Product Portfolio
  96. 7.16.5 CD Genomics Recent Developments
8 North America
  1. 8.1 North America Whole Plasmid Sequencing Revenue (2021-2032)
  2. 8.2 North America Whole Plasmid Sequencing Revenue by Type (2021-2032)
  3. 8.2.1 North America Whole Plasmid Sequencing Revenue by Type (2021-2026)
  4. 8.2.2 North America Whole Plasmid Sequencing Revenue by Type (2027-2032)
  5. 8.3 North America Whole Plasmid Sequencing Revenue Share by Type (2021-2032)
  6. 8.4 North America Whole Plasmid Sequencing Revenue by Application (2021-2032)
  7. 8.4.1 North America Whole Plasmid Sequencing Revenue by Application (2021-2026)
  8. 8.4.2 North America Whole Plasmid Sequencing Revenue by Application (2027-2032)
  9. 8.5 North America Whole Plasmid Sequencing Revenue Share by Application (2021-2032)
  10. 8.6 North America Whole Plasmid Sequencing Revenue by Country
  11. 8.6.1 North America Whole Plasmid Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Whole Plasmid Sequencing Revenue by Country (2021-2026)
  13. 8.6.3 North America Whole Plasmid Sequencing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Whole Plasmid Sequencing Revenue (2021-2032)
  2. 9.2 Europe Whole Plasmid Sequencing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Whole Plasmid Sequencing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Whole Plasmid Sequencing Revenue by Type (2027-2032)
  5. 9.3 Europe Whole Plasmid Sequencing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Whole Plasmid Sequencing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Whole Plasmid Sequencing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Whole Plasmid Sequencing Revenue by Application (2027-2032)
  9. 9.5 Europe Whole Plasmid Sequencing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Whole Plasmid Sequencing Revenue by Country
  11. 9.6.1 Europe Whole Plasmid Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Whole Plasmid Sequencing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Whole Plasmid Sequencing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Whole Plasmid Sequencing Revenue (2021-2032)
  2. 10.2 China Whole Plasmid Sequencing Revenue by Type (2021-2032)
  3. 10.2.1 China Whole Plasmid Sequencing Revenue by Type (2021-2026)
  4. 10.2.2 China Whole Plasmid Sequencing Revenue by Type (2027-2032)
  5. 10.3 China Whole Plasmid Sequencing Revenue Share by Type (2021-2032)
  6. 10.4 China Whole Plasmid Sequencing Revenue by Application (2021-2032)
  7. 10.4.1 China Whole Plasmid Sequencing Revenue by Application (2021-2026)
  8. 10.4.2 China Whole Plasmid Sequencing Revenue by Application (2027-2032)
  9. 10.5 China Whole Plasmid Sequencing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Whole Plasmid Sequencing Revenue (2021-2032)
  2. 11.2 Asia Whole Plasmid Sequencing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Whole Plasmid Sequencing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Whole Plasmid Sequencing Revenue by Type (2027-2032)
  5. 11.3 Asia Whole Plasmid Sequencing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Whole Plasmid Sequencing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Whole Plasmid Sequencing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Whole Plasmid Sequencing Revenue by Application (2027-2032)
  9. 11.5 Asia Whole Plasmid Sequencing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Whole Plasmid Sequencing Revenue by Country
  11. 11.6.1 Asia Whole Plasmid Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Whole Plasmid Sequencing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Whole Plasmid Sequencing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Whole Plasmid Sequencing Revenue (2021-2032)
  2. 12.2 SAMEA Whole Plasmid Sequencing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Whole Plasmid Sequencing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Whole Plasmid Sequencing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Whole Plasmid Sequencing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Whole Plasmid Sequencing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Whole Plasmid Sequencing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Whole Plasmid Sequencing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Whole Plasmid Sequencing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Whole Plasmid Sequencing Revenue by Country
  11. 12.6.1 SAMEA Whole Plasmid Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Whole Plasmid Sequencing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Whole Plasmid Sequencing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst